{"id":80771,"date":"2025-02-14T11:18:39","date_gmt":"2025-02-14T11:18:39","guid":{"rendered":"https:\/\/www.cofb.org\/?p=80771"},"modified":"2025-02-14T11:56:37","modified_gmt":"2025-02-14T11:56:37","slug":"farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/","title":{"rendered":"Farmac\u00e9uticos y farmac\u00e9uticas comunitarias se actualizan en el funcionamiento y uso de la bioimpedancia"},"content":{"rendered":"

El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) <\/strong>acogi\u00f3, el pasado 29 de enero, la conferencia<\/strong> "Bioimpedancia en el consejo farmac\u00e9utico"<\/strong>, con la colaboraci\u00f3n de Microcaya<\/a>. La formaci\u00f3n corri\u00f3 a cargo de Natalia Zaldua<\/strong>, del departamento cient\u00edfico y formativo de Microcaya y experta en bioimpedancia InBody. El vocal de Alimentaci\u00f3n y Nutrici\u00f3n de COFB, Oscar Llans\u00f3<\/strong>, coordin\u00f3 y moder\u00f3 la sesi\u00f3n dirigida a farmac\u00e9uticos y farmac\u00e9uticas de farmacia comunitaria.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Los objetivos<\/strong> de la formaci\u00f3n fueron revisar las herramientas para implementar protocolos de consejo alimenticio, conocer el funcionamiento y el uso de la bioimpedancia, dar el mejor consejo y realizar correctamente la recomendaci\u00f3n nutricional de acuerdo con la composici\u00f3n corporal.<\/p>\n\n\n\n

Llans\u00f3 present\u00f3 la formaci\u00f3n y, para empezar, defini\u00f3 qu\u00e9 es la bioimpedancia<\/strong>: \u201cfunciona para pasar una corriente el\u00e9ctrica de diversas frecuencias en la que, por principio f\u00edsico, la electricidad tiene una velocidad y una fuerza diferente dependiendo de la superficie, y nos extrapola la composici\u00f3n corporal\u201d. De esta forma, los investigadores fueron integrando la bioimpedancia en \u00e1mbitos como la nutrici\u00f3n, el deporte y la medicina. Se trata "de una herramienta innovadora para controlar la salud global de los pacientes en las oficinas de farmacia"<\/strong>, indic\u00f3 el vocal de Alimentaci\u00f3n y Nutrici\u00f3n del COFB.<\/p>\n\n\n\n

\u201cEsta t\u00e9cnica proporciona informaci\u00f3n valiosa sobre la composici\u00f3n corporal<\/strong>, incluyendo porcentajes de grasa, masa muscular, agua corporal y otros indicadores como el \u00e1ngulo de fase, que son esenciales para la salud\u201d.<\/p>\n\n\n\n

"Es una fotograf\u00eda, en un minuto, sobre cu\u00e1l es nuestro estado de salud"<\/strong>, asegur\u00f3 Natalia Zaldua<\/strong>. Tambi\u00e9n comparti\u00f3 los principios de medida de la composici\u00f3n corporal, introdujo los conceptos de resistencia (Xc) y reactancia (R), as\u00ed como de\u00e1ngulo de fase (an\u00e1lisis de la salud celular)<\/strong>, "el par\u00e1metro de la bioimpedancia establecido para el diagn\u00f3stico de la desnutrici\u00f3n y el pron\u00f3stico cl\u00ednico"<\/strong>.<\/p>\n\n\n\n

\"Natalia<\/a>
Natalia Zaldua durante su presentaci\u00f3n. <\/figcaption><\/figure>\n\n\n\n

Sin embargo, durante la formaci\u00f3n, la experta en bioimpedancia indic\u00f3 c\u00f3mo interpretar la hoja de resultados del informe de bioimpedancia<\/strong>, donde se especifican conceptos como: la masa muscular, la masa grasa, el \u00edndice de masa corporal, la hidrataci\u00f3n corporal, el metabolismo basal, el edema o la retenci\u00f3n de l\u00edquidos, la relaci\u00f3n entre masa muscular y masa grasa y la distribuci\u00f3n de grasa.<\/p>\n\n\n\n

Durante la segunda parte de la sesi\u00f3n, se llev\u00f3 a cabo una parte pr\u00e1ctica en la que se expusieron diferentes casos pr\u00e1cticos<\/strong> para ejemplificar c\u00f3mo realizar una correcta medici\u00f3n y elaboraci\u00f3n de informes en la farmacia comunitaria y protocolos de seguimiento.<\/p>\n\n\n\n

\n\n\n\n

Ventajas de la bioimpedancia en las oficinas de farmacia<\/strong><\/h2>\n\n\n\n

El vocal de Alimentaci\u00f3n y Nutrici\u00f3n de Colegio detall\u00f3 cu\u00e1les son las principales ventajas de la bioimpedancia para las oficinas de farmacia:<\/p>\n\n\n\n

    \n
  1. Evaluaci\u00f3n completa de la composici\u00f3n corporal:<\/strong> A diferencia de las balanzas tradicionales, la bioimpedancia permite evaluar la composici\u00f3n corporal de los pacientes, proporcionando datos sobre la masa muscular y la grasa corporal, as\u00ed como el estado de hidrataci\u00f3n.<\/li>\n\n\n\n
  2. Prevenci\u00f3n de enfermedades cr\u00f3nicas:<\/strong> Un seguimiento regular de la composici\u00f3n corporal puede ayudar a identificar factores de riesgo asociados a enfermedades como la diabetes, la obesidad y las enfermedades cardiovasculares, lo que permite una intervenci\u00f3n precoz, gracias a los \u00edndices de hidrataci\u00f3n intracelular o el \u00e1ngulo de fase.<\/li>\n\n\n\n
  3. Personalizaci\u00f3n de planes de salud:<\/strong> Los resultados de la bioimpedancia permiten a los farmac\u00e9uticos comunitarios ofrecer recomendaciones personalizadas sobre alimentaci\u00f3n y ejercicio, adaptadas a las necesidades individuales de cada paciente.<\/li>\n\n\n\n
  4. Motivaci\u00f3n y seguimiento:<\/strong> Los pacientes pueden ver sus progresos de forma m\u00e1s clara a trav\u00e9s de los datos proporcionados por la bioimpedancia, lo que puede aumentar su motivaci\u00f3n por seguir un estilo de vida saludable.<\/li>\n<\/ol>\n\n\n\n
    \"\"<\/a>
    Oscar Llans\u00f3 en un momento de su intervenci\u00f3n. <\/figcaption><\/figure>\n\n\n\n

    \u201cA trav\u00e9s de la incorporaci\u00f3n de la bioimpedancia, las oficinas de farmacia se posicionan como centros de salud integral, donde los pacientes pueden recibir una atenci\u00f3n personalizada y eficaz<\/strong>. \u00c9sta iniciativa<\/strong> no s\u00f3lo mejora la salud individual de los pacientes, sino que tambi\u00e9n contribuye a la salud p\u00fablica en general,<\/strong> ya que esta tecnolog\u00eda se puede utilizar como prevenci\u00f3n de enfermedades\u201d, asegur\u00f3 Llans\u00f3.<\/p>\n\n\n\n<\/div>\n\n\n\n

    Con la colaboraci\u00f3n de:<\/strong><\/p>\n\n\n\n

    \"\"<\/a><\/figure>","protected":false},"excerpt":{"rendered":"

    El Colegio de Farmac\u00e9uticos de Barcelona (COFB) acogi\u00f3, el pasado 29 de enero, la conferencia "Bioimpedancia en el consejo farmac\u00e9utico", con la colaboraci\u00f3n de Microcaya. La formaci\u00f3n corri\u00f3 a cargo de Natalia Zaldua, del departamento cient\u00edfico y formativo de Microcaya y experta en bioimpedancia InBody. El vocal de Alimentaci\u00f3n [\u2026]<\/p>","protected":false},"author":3,"featured_media":80776,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,5254,18,19,37,53,69,76,262],"class_list":["post-80771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-bioimpedancia","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-consell-farmaceutic","tag-farmaceutics","tag-farmacia-comunitaria","tag-oficina-de-farmacia","tag-oficines-de-farmacia"],"yoast_head":"\nFarmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-14T11:18:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-14T11:56:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s’actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia\",\"datePublished\":\"2025-02-14T11:18:39+00:00\",\"dateModified\":\"2025-02-14T11:56:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\"},\"wordCount\":760,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"bioimped\u00e0ncia\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"consell farmac\u00e8utic\",\"farmac\u00e8utics\",\"farm\u00e0cia comunit\u00e0ria\",\"Oficina de farm\u00e0cia\",\"oficines de farm\u00e0cia\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\",\"name\":\"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg\",\"datePublished\":\"2025-02-14T11:18:39+00:00\",\"dateModified\":\"2025-02-14T11:56:37+00:00\",\"description\":\"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s’actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/","og_locale":"es_ES","og_type":"article","og_title":"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","og_url":"https:\/\/www.cofb.org\/es\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-02-14T11:18:39+00:00","article_modified_time":"2025-02-14T11:56:37+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Berta Mart\u00ednez","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s’actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia","datePublished":"2025-02-14T11:18:39+00:00","dateModified":"2025-02-14T11:56:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/"},"wordCount":760,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg","keywords":["Atenci\u00f3 farmac\u00e8utica","bioimped\u00e0ncia","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","consell farmac\u00e8utic","farmac\u00e8utics","farm\u00e0cia comunit\u00e0ria","Oficina de farm\u00e0cia","oficines de farm\u00e0cia"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/","url":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/","name":"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s'actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg","datePublished":"2025-02-14T11:18:39+00:00","dateModified":"2025-02-14T11:56:37+00:00","description":"El passat 29 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/02\/14\/farmaceutics-i-farmaceutiques-comunitaries-sactualitzen-en-el-funcionament-i-lus-de-la-bioimpedancia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e8utics i farmac\u00e8utiques comunit\u00e0ries s’actualitzen en el funcionament i l\u2019\u00fas de la bioimped\u00e0ncia"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/02\/COFB_BIOIMPEDANCIA_12022025-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va acollir, el passat 29 de gener, la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya. La formaci\u00f3 va anar a c\u00e0rrec de Natalia Zaldua, del departament cient\u00edfic i formatiu de Microcaya i experta en bioimped\u00e0ncia InBody. El vocal d\u2019Alimentaci\u00f3 […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=80771"}],"version-history":[{"count":19,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80771\/revisions"}],"predecessor-version":[{"id":80808,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80771\/revisions\/80808"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/80776"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=80771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=80771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=80771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}